Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma: Correlation with TNM stage and disease free and overall survival

Cancer

Volumn 78, Issue 10, 1996, Pages 2111-2118

  Bréchot, Jeanne Marie ^a   Chevret, Sylvie ^b   Charpentier, Marie Christine ^a   Appere De Vecchi, Corinne ^a   Capron, Frédérique ^c   Prudent, Jacques ^a   Rochemaure, Jacques ^a   Chastang, Claude ^b  

^a HÔTEL DIEU   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c Service d'Anatomie Pathologique   (France)

Author keywords

blood vessel invasion; lymphatic vessel invasion; nonsmall cell lung carcinoma; prognosis; survival

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD VESSEL FUNCTION; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HISTOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; LYMPHANGIOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BLOOD VESSELS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; LYMPHATIC SYSTEM; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0029910834     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19961115)78:10<2111::AID-CNCR11>3.0.CO;2-1     Document Type: Article

References (29)

1. Mountain CF. Lung cancer staging classification. Clin Chest Med 1993;14:45-53.
2. Mountain CF. A new international staging system for lung cancer. Chest 1986;89(Suppl):225-33.
3. Bénichou J, Fabre CH, Chastang CI, Lebeau B, Babo P, Rebishung JL, et al. Facteurs pronostiques du cancer du poumon opére non à petites cellules:étude à partir d'un essai thérapeutique randomisé. Rev Mal Resp 1987;4:301-9.
4. Naruke T, Goya T, Tsuchiya R, Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988;96:440-7.
5. Capewell S, Sudlow MF. Performance and prognosis in patients with lung cancer. Thorax 1990;45:951-6.
6. Yoshida T, Shirakusa T, Shigematsu N, Ushijima Y, Inokuchi K. Histopathological factors predictive for prognosis of lung cancer. Jpn J Surg 1979;9:210-7.
7. Higgins GA, Serlin O, Arnadeo JH, Mac Elkinney J, Kehn J. Gastric cancer: factors in survival. Chir Gastroenterol 1976; 10:393-8.
8. Barber HRK, Sommers SC, Rotterdam H, Kwon T. Vascular invasion as a prognostic factor in stage 1B cancer of the cervix. Obstet Gynecol 1978;52:343-8.
9. Cady B, Sedgwick CE, Meissner WA, Bookwalter JR, Romagosa V, Weber J. Changing clinical, pathologic, therapeutic and survival patterns in differentiated thyroid carcinoma. Ann Surg 1976;184:541-53.
10. Sampat MB, Sirsat MV, Gangadharan P. Prognostic significance of blood vessel invasion in carcinoma of the breast in women. J Surg Oncol 1977;9:623-32.
11. Weigand RA, Isenberg WM, Russo J, Brennan MJ, Rich MA, and the Breast Cancer Prognostic Study Associates. Blood vessel invasion and axillary lymph node involvement as prognostic indicators for human breast cancer.Cancer 1982;50:962-9.
12. Lee AKC, De Lellis RA, Silverman ML, Heatley GH, Wolfe HJ. Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast. J Clin Oncol 1990;8:1457-65.
13. Takise A, Kodama T, Shimosato Y, Watanabe S, Suemasu K. Histopathologic prognostic factors in adenocarcinomas of the peripheral lung less than 2 cm in diameter. Cancer 1988;61:2083-8.
14. Macchiarini P, Fontanini G, Hardin MJ, Chuanchieh H, Bigini D, Vignati S, et al. Blood vessel invasion by tumor cells predicts recurrence in completely resected T1N0M0 non-small cell lung cancer.J Thorac Cardiovasc Surg 1993; 106:80-9.
15. Ichinose Y, Hara N, Ohta M, Yano T, Maeda K, Asoh H, et al. Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small cell lung cancer? A multivariate prognostic factor analysis of 151 patients. J Thorac Cardiovasc Surg 1993;106:90-4.
16. Ogawa JI, Tsurumi T, Yamada S, Koide S, Shohtsu A. Blood vessel invasion and expression of sialyl Lewis and proliferating cell nuclear antigen in stage I non-small cell lung cancer. Relation to postoperative recurrence. Cancer 1994;73:1177-83.
17. Ichinose Y, Yano T, Yokoyama H, Inoue T, Asoh H, Katsuda Y. The correlation between tumor size and lymphatic vessel invasion in resected peripheral stage I non-small cell lung cancer. A potential risk of limited resection. J Thorac Cardiovasc Surg 1994;108:684-6.
18. Fujisawa T, Yamaguchi Y, Saitoh Y, Hiroshima K, Ohwada H. Blood and lymphatic vessel invasion as prognostic factors for patients with primary resected non-small cell carcinoma of the lung with intrapulmonary metastases. Cancer 1995; 76:2464-70.
19. World Health Organization. The World Health Organization: histological typing of lung tumors. Am J Clin Pathol 1982; 77:123-36.
20. Rosen PP. Tumor emboli in intramammary lymphatics in breast carcinoma:pathologic criteria for diagnosis and clinical significance. Pathol Annu 1983;18(Part 2):215-32.
21. Kaplan E, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
22. Peto R, Peto J. Asymptotically efficient rank invariant test procedures (with discussion). J R Stat Soc A 1972;135:185-206.
23. Cox DR. Regression models and life tables (with discussion). J R Stat Soc B 1972;34:187-220.
24. Bettelheim R, Mitchell D, Gusterson BA. Immunocytochemistry in the identification of vascular invasion in breast cancer. J Clin Pathol 1984;37:364-6.
25. Saigo P, Rosen PP. The application of immunohistochemical stains to identify endothelial-lined channels in mammary carcinoma. Cancer 1987;59:51-4.
26. Gilchrist KW, Gould VE, Hirschl S, Imbriglia JE, Patchefsky AS, Penner DW, et al. Interobserver variation in the identification of breast carcinoma in intra mammary lymphatics. Hum Pathol 1982;13:170-2.
27. Macchiarini P, Fontanini G, Hardin JM, Pingitore R, Angeletti CA. Most peripheral, node-negative, non-small cell lung cancers have low proliferative rates and to intratumoral and peritumoral blood and lymphatic vessel invasion. Rationale for treatment with wedge resection alone. J Thorac Cardiovasc Surg 1992;104:892-9.
28. Macchiarini P, Fontanini G, Dulmet E, De Montpreville V, Chapelier AR, Cerrina J, et al. Angiogenesis: an indicator of metastasis in non-small cell lung cancer invading the thoracic inlet. Ann Thorac Surg 1994;57:1534-9.
29. Yuan A, Yang PC, Yu CJ, Lee YC, Yao YT, Chen CL, et al. Tumor angiogenesis correlates with histologic type and metastasis in non-small-cell lung cancer. Am J Respir Crit Care Med 1995;152:2157-62.